Health insurance is a tough business because small changes in medical costs can move profits by hundreds of millions of dollars. That makes disciplined pricing and membership quality far more important than flashy revenue growth.
One fast-growing insurer just improved its cost outlook again while laying out an aggressive expansion plan for the next several years.
Tax Strategy (Sponsored)
Many investors overlook deductions that could help minimize capital gains tax, such as:
Eligible investment expenses
Selling costs tied to property
Each comes with IRS rules and reporting requirements. That’s why consulting a fiduciary financial advisor is often recommended.
See Advisor Matches.
*This is not an offer to buy or sell any security or interest. All investing involves risk, including loss of principal. Working with an adviser may come with potential downsides such as payment of fees (which will reduce returns). Past performance is not a guarantee of future results. There are no guarantees that working with an adviser will yield positive returns. The existence of a fiduciary duty does not prevent the rise of potential conflicts of interest.
What Just Happened
Oscar Health, Inc. (NYSE: OSCR) used its September 16 Investor Day to raise 2026 earnings guidance for the second time in six weeks.
Management now expects earnings from operations between $600 million and $800 million, up from $500 million to $700 million previously.
It also improved its medical loss ratio outlook to 81% to 82% from 81.5% to 82.5%, while keeping revenue guidance at $18.7 billion to $19 billion.
That 50-basis-point MLR improvement sounds small, but on nearly $19 billion in annual revenue, it can meaningfully affect profit.
For a health insurer, paying out even slightly less of each premium dollar in medical claims can create substantial operating leverage.
Membership Growth Is Still The Engine
Oscar ended June with roughly 2.96 million members, up 46% from a year earlier.
That is unusually fast growth for a health insurer of this size, and it comes largely from the Affordable Care Act individual market where Oscar has spent years building its brand and technology platform.
The company now plans to expand into another 400 to 600 counties by 2029.
That gives you a straightforward growth path: enter more markets, price plans carefully, add members, and spread technology and administrative costs across a larger base.
The risk is that insurance growth can destroy value if pricing is too aggressive.
Oscar learned that lesson during earlier years when membership expansion came with heavy losses. The difference today is that membership is growing while underwriting performance is improving.
How many stocks are actually in the "Wilshire 5000" total-market index today?
Gold Before Change (Sponsored)
In 1971, one Sunday-night announcement changed the dollar almost overnight.
Today, investors are again asking what inflation, policy shifts, and rising central-bank gold demand could mean for retirement savings.
This free guide explains why gold is back in focus, how physical gold can fit into certain retirement strategies, and what some investors are doing to prepare before the next major monetary shift.
Get the Free Gold Guide Before the Next Move.
Medical Costs Are Moving In The Right Direction
The second quarter showed why the market has become much more interested in this story. Oscar's Q2 medical loss ratio fell to 79.2% from 91.1% a year earlier.
Revenue reached $4.88 billion, and earnings from operations swung to $388.6 million from a $230.5 million loss. For the first half, operating earnings reached roughly $1.09 billion.
That level will not repeat evenly across the year because health insurance is highly seasonal. Medical utilization tends to rise later in the year as more members meet deductibles, and Oscar also makes significant payments through the federal risk-adjustment program.
Still, the improved full-year guidance suggests management is seeing enough strength in claims trends to absorb that tougher second-half seasonality.
Elite Trade Club Insider
A Director Bought $1 Million Into A 60% Drawdown While A CEO Sold $7.7 Million After Record Results
You’re looking at one consumer growth stock still trying to prove a major brand expansion can pay off and one data infrastructure company delivering record results into the AI boom. Elite Trade Club Insider readers are seeing where insiders moved next: a director put $1 million of fresh capital into the beaten-down name, while another CEO sold $7.66 million after a powerful rerating.
You’re reading the free version. Here’s what we held back.
Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.
A subscription gets you:
The insider buys, options bets, and dark pool moves the free edition can't show you. Unlocked every weekday.
A Sunday Deep Dive that tells you where to look before Monday's bell rings.
The Friday Smart Money Brief: who bought, who sold, where the big options bets landed, and where institutions are hiding volume. Three data layers. One email.
A Monthly Insider Scorecard so you always know whether smart money is buying or selling the market.
Every past Insider edition, unlocked, on elitetrade.club. Go back and see what you missed.
$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.
Technology Is Improving The Economics
Oscar has always pitched itself as a technology-enabled insurer rather than a traditional carrier with a better app.
The platform handles enrollment, member engagement, claims data, provider information, and other parts of the insurance experience. As membership scales, the same technology base can support more revenue without administrative expenses rising at the same rate.
That is already showing up in the numbers. Oscar's Q2 SG&A expense ratio fell to 14.2% from 18.7% a year earlier, helped by fixed-cost leverage and tighter expense control.
The company is also trying to expand beyond its own insurance plans through businesses such as Lucie Health Marketplace and its technology operations.
Those are still smaller pieces of the story, but they give Oscar a path to monetize its platform without taking all of the insurance risk itself.
Market Leadership Shifts (Sponsored)
The first half of 2026 may have felt stable, but two powerful forces are now colliding.
AI is reshaping entire industries, while global trade and political alliances are becoming more fragile.
One analyst calls it The Age of Chaos.
And he believes many “safe” household-name stocks could be at risk, while a new group of companies may be positioned to lead the next market cycle.
In a free presentation, he reveals the specific stocks he believes investors should consider selling, plus the names he believes could thrive as this new era unfolds.
Stream the free presentation today and see the buy and sell list now.
*This ad is sent on behalf of Chaikin Analytics, 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. If you would like to optout from receiving offers from Chaikin Analytics please click here.
The Balance Sheet Gives It Room To Expand
Oscar ended June with roughly $4.08 billion in cash and another $4.48 billion in short-term investments.
Most of that capital sits within a regulated insurance structure and cannot simply be treated as excess cash available for buybacks. But it still gives the company considerable financial resources as it enters new counties and absorbs normal swings in claims.
The stronger balance sheet is important because rapid insurance growth consumes capital. Oscar needs enough reserves to support more members while satisfying state and federal requirements.
This is a very different position from the earlier turnaround years when the central question was whether Oscar could reach sustainable profitability at all.
Why The Stock Has A Case
The thesis is no longer simply that Oscar might someday become profitable.
It already produced more than $1 billion of operating earnings during the first half, has nearly 3 million members, and just raised its full-year operating-profit range by another $100 million at both ends.
The next phase is about proving those economics can survive continued expansion.
If Oscar can add hundreds of new counties without giving back its underwriting improvements, earnings could compound quickly because technology and corporate overhead do not need to grow as fast as premium revenue.
That is the upside you are paying for.
What Could Trip It Up
The biggest risk is medical-cost volatility. Oscar's relatively young and healthy membership also means it makes large risk-adjustment payments to plans with sicker populations.
Those estimates can move meaningfully as industry-wide claims data develops. ACA policy is another major variable. Subsidies, enrollment rules, risk-adjustment formulas, and federal healthcare policy can all influence membership and profitability.
Finally, the stock has already had a huge year. Expectations are much higher now, so even solid results can disappoint if medical trends stop improving.
My Take
Buy on pullbacks. Oscar has transformed from a high-growth insurer that struggled to make money into a company producing real operating profits while membership continues expanding.
Better medical-cost trends, improving administrative leverage, and the 400-to-600-county expansion plan give you multiple ways for earnings to grow.
The key risk is underwriting discipline. Fast membership growth is valuable only if pricing keeps pace with claims. I would build the position on weakness rather than chase the stock after its strong run.
Action Recap
🏥 Looking to buy? Buy on pullbacks while medical-cost trends and operating guidance continue improving.
📈 Already own it? Keep holding while membership grows without pushing the MLR back higher.
⚠️ Main risk to respect: Rapid expansion can become expensive quickly if claims or risk-adjustment payments run above expectations.
You Read This Far. Here's Where the Real Work Lives.
We run three live portfolios on Autopilot, and everything about them is public: every position, every allocation, every trade, visible the moment it happens.
We keep our own money in each one, because analysis you won't fund yourself is just content.
THE UNBREAKABLE STACK
Our growth book: durable software and cybersecurity names built to compound quietly for years.
THE HORMUZ PREMIUM
Our energy thesis: built for how that sector actually pays, over quarters, not headlines.
THE SQUEEZE
The defensive sleeve: staples and steady compounders, boring on purpose, built for the nights you'd rather sleep than watch futures.
And here's the part that makes it effortless: Autopilot does the trading for you. Connect the brokerage you already use (Robinhood, Schwab, Fidelity, and more) and every move we make gets mirrored in your own account automatically.
Your money never leaves your brokerage. It stays in your account, under your control, and you can override any trade or disconnect anytime. Autopilot even rebalances automatically when allocations drift, and you get a notification every time something happens.
No watching tickers. No timing entries. No fat-finger mistakes at market open. You pick the portfolio, we do the work, your account follows along.
Pick the one that fits your risk level, or run all three:
Live portfolios, real positions, our own capital at stake. Your funds stay in your own brokerage account. Past performance doesn't guarantee future results.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
